Chemokine receptor-4 targeted PET/CT imaging with 68Ga-Pentixafor in head and neck cancer—a comparison with 18F-FDG and CXCR4 immunohistochemistry
Loading...
Date
Authors
Hadebe, Bawinile
Harry, Lerwine
Gabela, Lerato
Masikane, Siphelele
Patel, Maryam
Zwane, Sizwe
Pillay, Venesen
Bipath, Presha
Cebekhulu, Nonhlanhla
Nyakale, Nozipho E.
Journal Title
Journal ISSN
Volume Title
Publisher
MDPI
Abstract
Please read abstract in article.
Description
DATA AVAILABITY STATEMENT: The raw data supporting the conclusions of this article will be made
available by the authors on request.
Keywords
Pentixafor, SDG-03: Good health and well-being, SDG-09: Industry, innovation and infrastructure, Head and neck squamous cell carcinoma (HNSCC), Positron emission tomography/computed tomography (PET/CT), Human immunodeficiency virus (HIV), Chemokine receptor 4 (CXCR4)
Sustainable Development Goals
SDG-03:Good heatlh and well-being
SDG-09: Industry, innovation and infrastructure
SDG-09: Industry, innovation and infrastructure
Citation
Hadebe, B.; Harry, L.;
Gabela, L.; Masikane, S.; Patel, M.;
Zwane, S.; Pillay, V.; Bipath, P.;
Cebekhulu, N.; Nyakale, N.; et al.
Chemokine Receptor-4 Targeted
PET/CT Imaging with
68Ga-Pentixafor in Head and Neck
Cancer—A Comparison with 18F-FDG
and CXCR4 Immunohistochemistry.
Diagnostics 2024, 14, 1375. https://doi.org/10.3390/diagnostics14131375.